Exane Asset Management’s AbbVie ABBV Stock Holding History

Exane Asset Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-103	Closed	-$28K	–	35
2025 Q3	$28K	Sell	103 -20,192	-99%	-$4.11M	0.01%	30
2025 Q2	$4.42M	Buy	+20,295	New	+$3.77M	1.73%	12
2018 Q4	–	Sell	-2,966	Closed	-$281K	–	109
2018 Q3	$281K	Buy	2,966 +2,397	+421%	+$227K	0.09%	56
2018 Q2	$52.7K	Sell	569 -5,231	-90%	-$511K	0.02%	97
2018 Q1	$549K	Buy	+5,800	New	+$637K	0.16%	49
2017 Q4	–	Sell	-2,800	Closed	-$249K	–	99
2017 Q3	$249K	Buy	2,800 +300	+12%	+$22.8K	0.05%	57
2017 Q2	$181K	Buy	+2,500	New	+$168K	0.06%	53

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Exane Asset Management's ABBV Position: Q4 2025 in Review

Exane Asset Management sold out of AbbVie (ABBV) in Q4 2025, closing a stake of 103 shares — an estimated $28K sold.

Exane Asset Management first reported a position in ABBV in Q2 2017 and held it in 7 quarters. The position peaked at $4.42M in Q2 2025. 4,156 funds tracked by Wall St. Rank hold ABBV as of Q4 2025.

Exane Asset Management reported no remaining AbbVie position as of Q4 2025 after selling out during the quarter.
Exane Asset Management sold 103 AbbVie shares in Q4 2025, an estimated $28K.
Exane Asset Management first reported a position in AbbVie in Q2 2017 and held it in 7 quarters.
Exane Asset Management's AbbVie position peaked at $4.42M in Q2 2025.
4,156 funds tracked by Wall St. Rank held AbbVie as of Q4 2025.

Based on Exane Asset Management's 13F filing for Q4 2025, filed 27 Jan 2026.